Metabolic Explorer Granted Patent for the production of Propylene Glycol
News Feb 27, 2006
Metabolic Explorer has announced that the FR2864967 Patent for the production of Propylene Glycol (MPG) by fermentation has been granted. The strain developed by Metabolic Explorer is designed to offer a competitive way to manufacture MPG from renewable resources.
METEX demonstrates its ability to develop proprietary strains with performant biochemical pathways using its integrated platform in strain evolution and optimisation.
This bioprocess that uses E. coli for the production of MPG and Acetone as co-product offers two advantages versus the current chemical process: The possibility to produce pure R or S MPG isomer when the chemical processes produces a racemic mixture. The bioprocess increases the value of MPG when it’s used as intermediates for performance products.
The use of renewable carbon sources when the chemical process uses propylene, a raw materiel with volatile and increasing price. The bioprocess offers a better and a sustainable economic for MPG production.
"The issuance of this new patent reinforces Metabolic Explorer’s pipeline of products positioning in industrial biotechnology," said Benjamin Gonzalez, CEO of Metabolic Explorer.
"Through this innovation we prove once again our capability to use our core competence to develop faster commodity chemicals using fermentation routes and to offer the chemical industry a unique value proposition for a better and sustainable growth."
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE